1-12 of 12
neoplasm grading
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Analysis of an Online Treatment Decision Tool Reveals Variances in Practice between Experts and Oncology Healthcare Providers for Newly Diagnosed Follicular Lymphoma

Rachael M Andrie, John M Burke, MD, Christopher R. Flowers, MD MS, Nathan H Fowler, MD, Jeff P. Sharman, MD, Timothy A Quill, PhD, Kevin L Obholz, PhD, Ian W. Flinn, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 414.
https://doi.org/10.1182/blood-2019-128988
Published: 2019
Journal Articles

Host and Tumor Factor XII Drive Ovarian Cancer Maintenance and Progression

Evi X Stavrou, MD, Kara L. Bane, M.Sc., Peronne Joseph, M.Sc., Anil Belur Nagaraj, PhD, Analisa Difeo, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2384.
https://doi.org/10.1182/blood-2019-125862
Published: 2019
Journal Articles

Fibrin As a Target for Glioblastoma Detection and Treatment

Lynn M Knowles, PhD, Carolin Wolter, MS, Ralf Ketter, MD, Steffi Urbschat, PhD, Stefan Linsler, MD, Simon Müller, MD, Andreas Müller, PhD, Hermann Eichler, Jan Pilch, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3630.
https://doi.org/10.1182/blood-2019-124089
Published: 2019
Journal Articles

Gene-Expression for Prediction of Disease Progression Following Initial Management of Follicular Lymphoma

Etienne Mahe, BSc, MD FRCPC, Ariz Akhter, PhD, Danielle H. Oh, MB ChB, Fahad Farooq, BSc, Meer-Taher Shabani-Rad, MD FRCPC, Adnan Mansoor, MD FRCPC, Douglas A. Stewart, MD FRCPC
Journal: Blood
Blood (2015) 126 (23): 4804.
https://doi.org/10.1182/blood.V126.23.4804.4804
Published: 2015
Journal Articles

Differential Expression of Enhancer of Zeste Homolog 2 (EZH2) Protein in Low and High Grade B-Cell Non-Hodgkin Lymphomas and Differential Regulation of EZH2 Expression By p-ERK and MYC in High Grade B Cell Lymphomas

Xuejun Tian, MD/PhD, Ali Shahsafaei, David M. Dorfman, MD PhD
Journal: Blood
Blood (2015) 126 (23): 2660.
https://doi.org/10.1182/blood.V126.23.2660.2660
Published: 2015
Journal Articles

Silencing of HSP70 and TRIAP1 Genes in Multiple Myeloma Cell Lines Induces Apoptosis through Apaf-1/Caspase 9 Pathway: New Potential Targets on the Way?

Veruska Lia Fook Alves, MsC, Gisele Wally Braga Colleoni, Daniela Bertolli Zanatta, Bryan E. Strauss
Journal: Blood
Blood (2014) 124 (21): 5175.
https://doi.org/10.1182/blood.V124.21.5175.5175
Published: 2014
Journal Articles

Functional Studies Of H sp70 Gene Expression In Multiple Myeloma Cell Lines Suggest That This Gene Inhibition Can Be a Potential Therapeutic Target, Independent Of 17p/p53 Status

Veruska Lia Fook Alves, Walter Moises Tobias Braga, M.D., Daniela Bertolli Zanatta, Fabricio de Carvalho, Maria de Lourdes Chauffaille, Bryan E. Strauss, Gisele Wally Braga Colleoni, MD
Journal: Blood
Blood (2013) 122 (21): 3771.
https://doi.org/10.1182/blood.V122.21.3771.3771
Published: 2013
Journal Articles

An IHC Screen For EphA3 Positive FFPE Tumors

Darren Locke, PhD, Steven Bernstein, PhD, Frank Lynch, PhD, Koushan Siami-Namini, MD, FCAP, Jackie M. Walling, MBChB, PhD, Thomas Yonker, Geoffrey Yarranton, PhD
Journal: Blood
Blood (2013) 122 (21): 4965.
https://doi.org/10.1182/blood.V122.21.4965.4965
Published: 2013
Journal Articles

Response Assessment Using Early and End-of-Treatment 18F-FLT PET Can Predict Outcome in Patients with Non-Hodgkin Lymphoma,

Hyewon Lee, Seok-Ki Kim, Tae Sung Kim, Se Hun Kang, Weon Seo Park, Hyeon Seok Eom
Journal: Blood
Blood (2011) 118 (21): 3679.
https://doi.org/10.1182/blood.V118.21.3679.3679
Published: 2011
Journal Articles

Thrombin Enhances Spontaneous Tumor Growth and Cell Cycle Activation by Downregulation of p27 Kip1 and Upregulation of Skp2 and MiR-222

Liang Hu, Sherif Ibrahim, Cynthia Liu, Jeffrey Skaar, Michelle Pagano, Simon Karpatkin
Journal: Blood
Blood (2008) 112 (11): 396.
https://doi.org/10.1182/blood.V112.11.396.396
Published: 2008
Journal Articles

Identification of Combined Clinical and Biomarker Prognostic Factors in Follicular Lymphoma.

Cheryl J. Foster, BSc, Patricia L. Farmer, MD, Tara Baetz, MD, Julia Brettschneider, PhD, Harriet E. Feilotter, PhD, David P. LeBrun, MD
Journal: Blood
Blood (2006) 108 (11): 4603.
https://doi.org/10.1182/blood.V108.11.4603.4603
Published: 2006
Journal Articles

Time-Dependent Effect of Non-Hodgkin’s Lymphoma Grade on Disease Free Survival (DSF) of Relapsed/Refractory Patients Treated with High-Dose Chemotherapy (HDC) Plus Autologous Hematopoietic Stem Cell Transplant (AHSCT).

Pingfu Fu, PhD, Willem J. Van Heeckeren, MD, Punit D. Wadhwa, MD, David J. Bajor, Richard J. Creger, Phar D, Brenda W. Cooper, MD, Mary J. Laughlin, MD, Hillard M. Lazarus, MD, Stanton L. Gerson, MD, Omer N. Koc, MD
Journal: Blood
Blood (2004) 104 (11): 917.
https://doi.org/10.1182/blood.V104.11.917.917
Published: 2004